Australia's Orthocell rises as co secures US distributors for flagship product

Orthocell

23/04/2025 02:04

** Shares of Orthocell OCC.AX rise 8.1% to A$1.27, snap a four-day losing streak

** Stock set for its strongest session since April 10, if gains hold

** The biotech firm announces appointment of its first four U.S. distributors of its flagship nerve repair product Remplir

** Co says it is targeting to appoint about 10 U.S. distributors by June-end which would account for representation in around 25 states in the U.S.

** Stock down 7% YTD, including moves in current session

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((JasmeenAraIslam.Shaikh@thomsonreuters.com;))